Ewha Med J.  2021 Oct;44(4):146-147. 10.12771/emj.2021.44.4.146.

Ivermectin Treatment for COVID-19

• Ohe M

• KMID: 2521828
• DOI: http://doi.org/10.12771/emj.2021.44.4.146

Abstract

no abstract avaliable

Reference

1. Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM. 2020; The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral Res. 178:104787. DOI: 10.1016/j.antiviral.2020.104787. PMID: 32251768. PMCID: PMC7129059.

2. Lehrer S, Rheinstein PH. 2020; Ivermectin docks to the SARS-CoV-2 spike receptor-binding domain attached to ACE2. In Vivo. 34:3023–3026. DOI: 10.21873/invivo.12134. PMID: 32871846. PMCID: PMC7652439.

3. Zhang X, Song Y, Ci X, An N, Ju Y, Li H, et al. 2008; Ivermectin inhibits LPS-induced production of inflammatory cytokines and improves LPS-induced survival in mice. Inflamm Res. 57:524–529. DOI: 10.1007/s00011-008-8007-8. PMID: 19109745.

4. Ahmed S, Karim MM, Ross AG, Hossain MS, Clemens JD, Sumiya MK, et al. 2021; A five-day course of ivermectin for the treatment of COVID-19 may reduce the duration of illness. Int J Infect Dis. 103:214–216. DOI: 10.1016/j.ijid.2020.11.191. PMID: 33278625. PMCID: PMC7709596.

5. Prasad A. 2020; Early administration of ivermectin, azithromycin & doxycycline along with I.V. prednisolone in a case of COVID-19 disease may lead to early recovery? Int J Pharm Chem Anal. 7:149–150. DOI: 10.18231/j.ijpca.2020.023.

6. Wang J, Yang X, Li Y, Huang JA, Jiang J, Su N. 2021; Specific cytokines in the inflammatory cytokine storm of patients with COVID-19-associated acute respiratory distress syndrome and extrapulmonary multiple-organ dysfunction. Virol J. 18:117. DOI: 10.1186/s12985-021-01588-y. PMID: 34088317. PMCID: PMC8177255.

7. Chuang TY, Tsai MH, Wu LM, Ho SJ, Yeh PS, Liu YL, et al. 2021; Successful treatment of tocilizumab and ivermectin for a patient with ARDS due to COVID-19. J Microbiol Immunol Infect. 54:147–148. DOI: 10.1016/j.jmii.2020.09.007. PMCID: PMC7837228.

8. Rajter JC, Sherman MS, Fatteh N, Vogel F, Sacks J, Rajter JJ. 2021; Use of ivermectin is associated with lower mortality in hospitalized patients with coronavirus disease 2019: the ivermectin in COVID nineteen study. Chest. 159:85–92. DOI: 10.1016/j.chest.2020.10.009. PMID: 33065103. PMCID: PMC7550891.

9. Hashim HA, Maulood MF, Ali CL, Rasheed AM, Fatak DF, Kabah KK, et al. 2021; Controlled randomized clinical trial on using ivermectin with doxycycline for treating COVID-19 patients in Baghdad, Iraq. Iraqi JMS. 19:107–115. DOI: 10.1101/2020.10.26.20219345.